Company name: Blue Sky Biologicals
Description: Provider of cannabinoid products and formulations, based in Vancouver, Canada. The company’s products include pet products, consumer products and CBD oils, water, sports drink, nootropics and non-alcoholic beverages, enabling its clients to heal themselves through pure, whole foods and supplements.
Industry: Healthcare | Group: | Code:
State: British Columbia
Start up capital raised (USD Million):
Business status: Generating Revenue
Ownership: Privately Held (no backing)
Revenue (USD Million):
Gross profit (USD Million):
Net income (USD Million)
Earnings before interest, tax, depreciation and amortization (EBITDA):
Financing Status: The company is in talks to be acquired by Cannalife Capital for an undisclosed amount on July 6, 2019.
Number of active investors:
Profile last updated:
Last known valuation:
Last known valuation date: